FIELD: chemistry.
SUBSTANCE: invention relates to crystalline form of B (3-cyano-1N-indol-7-yl)-[4-(4-fluorophenethyl)piperazin-1-yl] methanone hydrochloride, as well as to synthesis method thereof by passing HCl gas through a solution of (3-cyano-1N-indol-7-yl)-[4-(4-fluorophenethyl)piperazin-1-yl] methanone, separating the formed residue from the reaction mixture and drying.
EFFECT: end product can be used in medicine as a medicinal agent which has antagonistic effect on 5-HT2A receptor.
4 cl, 4 dwg, 4 tbl, 4 ex
Authors
Dates
2010-03-10—Published
2005-09-08—Filed